Arrhythmias & electrophysiology

Outcomes of Atrial Fibrillation Ablation in Heart Failure Subtypes

Circ Arrhythm ElectrophysiolPublished Prospective registry cohort study

Authors' conclusion

AF recurrence rates after CA were higher in patients with HF compared with those without HF, with patients with HFpEF being at the highest risk of recurrence. Nonetheless, CA was associated with a significant reduction in AF symptoms, AF-related hospitalization, and HF symptoms in most patients irrespective of HF subtypes.

Study context

Population
All patients undergoing atrial fibrillation (AF) catheter ablation at a tertiary center, 2013–202180% no Heart Failure (HF), 8% HFrEF, 7% HF with Mildly Reduced Ejection Fraction (HFmrEF), 5% HF with Preserved Ejection Fraction (HFpEF)
Participants
7,020 patients
Exposure
AF ablation outcomes by HF subtype
Outcome
AF recurrence
Follow-up
3 years
Methodological detailssingle-centre (tertiary center)
  • Single-centre (tertiary center)

Main finding

As reported in the abstract

Cumulative incidence of AF recurrence after ablation
Multivariable Cox
Each group vs no HFHazard ratio (95% CI)P value
HFpEF
1.47(1.21–1.78)
P < 0.05
HFmrEF
1.23(1.04–1.45)
P < 0.05
HFrEF
1.17(1.01–1.37)
P < 0.05

Observational data: associations, not effects.

Secondary outcomes

OutcomeNo HFHFrEFHFmrEFHFpEF
AF-related hospitalization, mean rate per 1 patient-year, before vs after CA
Before CA11.11.11.8
After CA0.10.20.20.3
AF-related hospitalization, mean rate per 1 patient-year, before vs after catheter ablation (CA) — Significant reduction in all groups
P<0.01 for each comparison

Quality of life (AF symptom severity score and AF burden score), baseline vs follow-up

Significant improvement in all groups for each score
P < 0.01

Original publication

Outcomes of Atrial Fibrillation Ablation in Heart Failure Subtypes. Circ Arrhythm Electrophysiol. Published 28 August 2024. doi:10.1161/circep.124.012926

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.